Hematologic Disorders

Anemia of Chronic Disease


Braunstein, E. M. (2020). Anemia of chronic disease. Merck Manual. http://www.merckmanuals.com/professional/hematology-and-oncology/anemias-caused-by-deficient-erythropoiesis/anemia-of-chronic-disease


Domino, F. (Ed.). (2020). The 5-Minute Clinical Consult Standard 2020 (25th ed.) Wolters Kluwer.


Goroll, A. &. Mulley, A. (2020). Primary Care Medicine: Office Evaluation and Management of the Adult Patient (8th ed.). Wolters Kluwer.


Lanier, J. B., Park, J. P., & Callahan, R. C. (2018). Anemia in older adults. American Family Physician, 98(7), 437-442A. doi: 897563568


Sennett, M. M. (2017). Anemia. In T. M. Buttaro, J. Trybulski, P. Polgar-Baily, & J. Sandberg-Cook (Eds.). Primary Care: A Collaborative Practice. (5th Ed.). (pp. 1278-1297.). Elsevier.


Teke, H. U., Cansu, D. U., Yildiz, P., Temiz, G., & Bal, C. (2017). Clinical significance of serum IL6, hepcidin, and EPO levels in anemia of chronic disease and iron deficiency anemia: The laboratory indicators for anemia. Biomedical Research, 28(6), 2704-2710.


Weiss, G. (2015). Anemia of chronic disorders: new diagnostic tools and new treatment strategies. Seminars in Hematology, 52(4), 313-320. doi: 10.1053/j.seminhematol.2015.07.004


Folic Acid Deficiency


Argyridis, S. (2019). Folic acid in pregnancy. Obstetrics, Gynaecology & Reproductive Medicine, 29(4), 118-120. https://doi.org/10.1016/j.ogrm.2011.02.005


Coffey-Vega, K. (2018). Folic acid deficiency. Medscape. https://emedicine.medscape.com/article/200184

Cordero, A., Crider, K., Rogers, L., Cannon, M., & Berry, R. J. (2015). Optimal serum and red blood cell folate concentrations in women of reproductive age for prevention of neural tube defects: World Health Organization guidelines. Morbidity and Mortality Weekly Report, 64(15), 421-423. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6415a5.htm


Likis, F. (2016). Folic acid. Journal of Midwifery and Women’s Health, 61(5), 673-674. Doi: 10.1111/jmwh.12546


Moll, R., & Davis, B. (2017). Iron, vitamin B12 and folate. Medicine, 45(4), 198-203. Doi: 10.1016/j.mpmed.2017.01.007


U.S. Preventive Services Task Force. (2017). Folic acid supplementation for the prevention of neural tube defects: U.S. Preventive Services Task Force recommendation statement. JAMA, 317 (2) 183-189. Doi: 10.1001/jama.2016.19438


Glucose-6-Phosphate Dehydrogenase Deficiency


Bubp, J., Jen, M., Matuszewski, K. (2015). Caring for glucose-6-phosphate dehydrogenase (G6PD)-deficient patients: implications for pharmacy. Pharmacy & Therapeutics, 40(9), 572–574.


Liu, H., Liu, W., Tang, X., Wang, T. (2015). Association between G6PD deficiency and hyperbilirubinemia in neonates: a meta-analysis. Pediatric Hematology and Oncology, 32:92. doi: 10.3109/08880018.2014.887803


Nagala, S. (2020). Glucose-6-phosphate dehydrogenase deficiency. http://emedicine.medscape.com/article/200390-overview


National Library of Medicine. (2020). Glucose-6-phosphate dehydrogenase deficiency. https://ghr.nlm.nih.gov/condition/glucose-6-phosphate-dehydrogenase-deficiency#statistics


Richardson, S. R., & O'Malley, G. F. (2019). Glucose 6 phosphate dehydrogenase (G6PD) deficiency. Stat Pearls. https://www.ncbi.nlm.nih.gov/books/NBK470315/


Yang, W.C., Tai, S., Hsu, C. L., Fu, C. M., Chou, A. K., Shao, P. L., Li, M. J. (2020). Reference levels for glucose-6-phosphate dehydrogenase enzyme activity in infants 7-90 days old in Taiwan. Journal of the Formosa Medical Association. 119(1 Pt 1), 69-74. doi: 10.1016/j.jfma.2019.03.010


Human Immunodeficiency Virus


Centers for Disease Control and Prevention. (2020). HIV Surveillance Report: diagnosis of HIV infection in the United States and dependent areas. https://www.cdc.gov/hiv/statistics/overview/index.html


Centers for Disease Control and Prevention. (2019). HIV Basics. https://www.cdc.gov/hiv/basics/index.html


Centers for Disease Control and Prevention. (2018). 2018 Quick Reference Guide: Recommended laboratory testing algorithm for serum or plasma specimens. https://stacks.cdc.gov/view/cdc/50872


Centers for Disease Control and Prevention. (2016). Updated guidelines for antiretroviral postexposure prophylaxis after sexual, injection drug use, or other non-occupational exposure to HIV—United States, 2016. https://www.cdc.gov/hiv/pdf/programresources/cdc-hiv-npep-guidelines.pdf


Centers for Disease Control and Prevention. (2015). Sexually transmitted diseases treatment guidelines. https://www.cdc.gov/std/tg2015/default.htm


U.S. Department of Health and Human Services. Panel on Antiretroviral Guidelines for Adults and Adolescents. (2019). Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. https://aidsinfo.nih.gov/contentfiles/lvguidelines/AdultandAdolescentGL.pdf


U.S. Public Health Service. (2017). Preexposure prophylaxis for the prevention of HIV infection in the United States-2017 Update. https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2017.pdf


U.S. Public Health Service. (2018). Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HIV and Recommendations for Postexposure Prophylaxis. https://stacks.cdc.gov/view/cdc/20711


Immune Thrombocytopenia


Kessler, C. M. (2020). Immune thrombocytopenia purpura. Medscape. https://emedicine.medscape.com/article/202158-overview


Khan, A. M, Mydra, H. & Nevarez, A. (2017). Clinical practice updates in the management of immune thrombocytopenia. Pharmacy and Therapeutics, 42(12): 756-763. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5720488/


Kuhne, T. (2017). Diagnosis and management of immune thrombocytopenia in childhood. Hamostaseologie, 37(1):36-44. doi: 10.5482/HAMO-16-06-0017


Mithoowani, S. & Arnold, D. (2019). First-line therapy for immune thrombocytopenia. Hamostaseologie, 39(3), 259-265. doi: 10.1055/s-0039-1684031


Silverman, M.A. (2017). Idiopathic thrombocytopenia purpura (ITP) in emergency medicine differential diagnoses. Medscape. https://emedicine.medscape.com/article/779545-differential


Iron Deficiency Anemia


BMJ Publishing Group. (2017). Iron Deficiency Anemia. BMJ Best Practice. http://bestpractice.bmj.com/topics/en-gb/94


Goroll, A. & Mulley, A.G. (2020). Primary Care Medicine: Office Evaluation and Management of the Adult Patient (8th ed.). Wolters Kluwer.


Harper, J. L. (2020). Iron deficiency anemia. Medscape. https://emedicine.medscape.com/article/202333


Hollier, A. (Ed.). (2018). Clinical Guidelines in Primary Care. (3rd ed.). Advanced Practice Education Associates.


Jimenez, K., Kulnigg-Dabsch, S., Gasche, C. (2015). Management of iron deficiency anemia. Gastroenterology and Hepatology 11(4), 241-250.


MPR Publications. (2020). Monthly Prescribing Reference. Haymarket Media.



Lead Toxicity


Agency for Toxic Substances & Disease Registry. (2019). Lead toxicity. How should patients exposed to lead be treated and managed? https://www.atsdr.cdc.gov/csem/csem.asp?csem=34&po=14


Centers for Disease Control & Prevention. (2019). Childhood lead poisoning prevention: Data and statistics. https://www.cdc.gov/nceh/lead/data/index.htm


Centers for Disease Control & Prevention. (2019). Childhood lead poisoning prevention: Laboratory considerations. https://www.cdc.gov/nceh/lead/lab/default.htm


Centers for Disease Control & Prevention. (2019). Childhood lead poisoning prevention: Lead poisoning prevention. https://www.cdc.gov/nceh/lead/prevention/default.htm


Council on Environmental Health. (2016). Prevention of childhood lead toxicity. Pediatrics, 138(1). DOI: https://doi.org/10.1542/peds.2016-1493


Pranay, K., Rowden, A., &O’Malley, R. (2020). Lead toxicity. Medscape. https://emedicine.medscape.com/article/1174752-overview


Leukemias


National Cancer Institute. (2020). Adult acute lymphoblastic leukemia treatment. http://www.cancer.gov/types/leukemia/hp/adult-all-treatment-pdq


National Cancer Institute. (2020). Adult acute myeloid leukemia treatment. http://www.cancer.gov/types/leukemia/hp/adult-aml-treatment-pdq


National Cancer Institute. (2017). Childhood acute lymphoblastic leukemia treatment. http://www.cancer.gov/types/leukemia/hp/child-all-treatment-pdq


National Cancer Institute. (2020). Childhood acute myeloid leukemia treatment. http://www.cancer.gov/types/leukemia/hp/child-aml-treatment-pdq


National Cancer Institute. (2020). Chronic lymphocytic leukemia treatment. http://www.cancer.gov/types/leukemia/hp/cll-treatment-pdq


National Cancer Institute. (2020). Chronic myelogenous leukemia treatment. http://www.cancer.gov/types/leukemia/hp/cml-treatment-pdq


National Cancer Institute. (2020). Hairy cell leukemia. http://www.cancer.gov/types/leukemia/hp/hairy-cell-treatment-pdq


Wu, L. (2019). Ophthalmologic manifestations of leukemias. Medscape. http://emedicine.medscape.com/article/1201870


Lymphoma


Charpentier, A. M., Friedman, D. L., Wolden, S., et al. (2016). Predictive factor analysis of response-adapted radiation therapy for chemotherapy-sensitive pediatric Hodgkin lymphoma: analysis of the Children's Oncology Group AHOD 0031 Trial. International Journal of Radiation Oncology Biology and Physics, 96(5), 943-950. doi: 10.1016/j.ijrobp.2016.07.015


Friedman, D.L., Chen, L., Wolden, S., et al. (2014). Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk Hodgkin lymphoma: a report from the Children's Oncology Group Study AHOD0031. Journal of Clinical Oncology, 32(32), 3651-8. doi: 10.1200/JCO.2013.52.5410


Kline, N., Bryant, R., Carlson, C. Hooke, M. & Nixon, C. (2014). Essentials of Pediatric Hematology/Oncology Nursing: A Core Curriculum (4th ed.) Association of Pediatric Hematology/Oncology Nurses.


Lash, B. W. (2018). Hodgkin lymphoma. Medscape. https://emedicine.medscape.com/article/201886-overview


Rosolen, A., Perkins, S. L., Pinkerton, C. R., et al. (2015). Revised International Pediatric Non-Hodgkin Lymphoma Staging System. Journal of Clinical Oncology, 33(18), 2112-2118. doi: 10.1200/JCO.2014.59.7203


Sandlund, J. T., Guillerman, R. P., Perkins, S. L., et al. (2015). International pediatric non-Hodgkin lymphoma response criteria. Journal of Clinical Oncology, 33, 2106-2111. doi: 10.1200/JCO.2014.59.0745


Vinjamaram, S. (2019). Non-Hodgkin lymphoma. Medscape. https://emedicine.medscape.com/article/203399


Neonatal Hyperbilirubinemia


Akpan, U. et al. (2019). The hematopoietic system. In A. Jnah & A. Trembath (Eds). Fetal and Neonatal Physiology for the Advanced Practice Nurse. Springer Publishing.


American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. (2004). Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation, 114 (1), 297-316. doi.org/10.1542/peds.114.1.297


Bagwell, G. A. & Steward, D. K. (2020). Hematologic system. In C. Kenner, L. Altimier, & M. Boykova (Eds). Comprehensive Neonatal Nursing Care. Springer Publishing.


Hanson, T. (2017). Neonatal jaundice treatment and management. Medscape. https://emedicine.medscape.com/article/974786-treatment


Itoh, S., Okada, H., Kuboi, T. & Kusaka, T. (2017). Phototherapy for neonatal jaundice. Pediatrics International, 59, 959-966, doi: 10.1111/ped.13332


Mitra, S. & Rennie, J. (2017). Neonatal jaundice: aetiology, diagnosis and treatment. British Journal of Hospital Medicine, 78(12), 699-704. doi: 10.12968/hmed.2017.78.12.699


Polycythemia Vera


Arber, D. A., Orazi, A., Hasserjian, R., Thiele, J., Borowitz, M. J., Le Beau, M. M., Vardiman, J. W. (2016). The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127(20), 2391-2405. https://doi.org/10.1182/blood-2016-03-643544


Jaffe, E. S., Arber, D. A., Campo, E., Harris, N. L., & Quintanilla-Martinez, L. (2017). Principles of classification of myeloid neoplasms. In Hematopathology. (2nd ed.). Elsevier.


McMullin, M. F., Harrison, C. N., Ali, S., Cargo, C., Chen, F., Ewing, J. … Mead, A. J. (2018). A guideline for the diagnosis and management of polycythemia vera. A British Society for Haematology guideline. British Journal of Haematology, 184, 176-191. doi: 10.1111/bjh.15648.


Prchal, J.F. & Prchal J.T. (2016). Polycythemia vera. In K. Kauschansky, et al. (Eds.) Williams Hematology. McGraw-Hill.


Tefferi, A., & Barbui, T. (2019). Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management. American Journal of Hematology, 94(1), 162-173. doi: 10.1002/ajh.25303


Rh Incompatibility


Aitken, S. L. & Tichy, E. M. (2015). RhD immune globulin products for prevention of alloimmunization during pregnancy. American Journal of Health-System Pharmacy, 72, 267-276. doi.org/10.2146/ajhp140288


Akpan, U. et al. (2019). The hematopoietic system. In A. Jnah & A. Trembath (Eds). Fetal and Neonatal Physiology for the Advanced Practice Nurse. Springer Publishing.


Bagwell, G.A. & Steward, D.K. (2020). Hematologic system. In C. Kenner, L. Altimier, & M. Boykova (Eds). Comprehensive Neonatal Nursing Care. Springer Publishing.


Kedrion Biopharma. (2019). Rhogam prescribing information. http://www.rhogam.com/


Maisels, M. & Watchko, J. (2016). Jaundice. In M. MacDonald and M. Seshia (Eds). Avery’s Neonatology-Pathophysiology and Management of the Newborn. Wolters Kluwer.


Sickle Cell Anemia


Cennimo, D. (2019). Parvovirus B19 infection: background, pathophysiology, epidemiology. Medscape. http://emedicine.medscape.com/article/961063


Centers for Disease Control and Prevention. (2019). Sickle cell disease data & statistics. https://www.cdc.gov/ncbddd/sicklecell/data.html


Chou, S. T., Alsawas, M., Fasano, R. M., Field, J. J., Hendrickson, J. E., Howard, J., Kameka, M., Kwiatkowski, J. L., Pirenne, F., Ahi, P. A., Stowell, S. R., Thein, S. L., Westhoff, C. M., Wong, T. E., Akl, E. A. (2020). American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support. Blood Advances, 28(4), 327-355. DOI: 10.1182/bloodadvances.2019001143


Hollier, A. (Ed.). (2018). Sickle cell anemia. In Clinical Guidelines in Primary Care. (3rd ed.) Advanced Practice Education Associates.


Maakaron, J. (2020). Sickle cell anemia. Medscape. http://emedicine.medscape.com/article/205926


National Heart, Lung and Blood Institute. (2014). Evidence-based management of sickle cell disease: expert panel report, 2014. https://www.nhlbi.nih.gov/health-topics/evidence-based-management-sickle-cell-disease


Thalassemia


Advani, P. (2019). Beta thalassemia. Medscape. https://emedicine.medscape.com/article/206490


Cheerva, A. C. (2018). Alpha thalassemia. Medscape. https://emedicine.medscape.com/article/955496-overview


Chonat, S. & Quinn, S. (2017). Current standards of care and long-term outcomes for thalassemia and sickle cell disease. Advances in Experimental Medicine and Biology, 1013(1), 59-87. DOI: 10.1007/978-1-4939-7299-9_3


Kline, N., Bryant, R., Carlson, C. Hooke, M. & Nixon, C. (2014). Essentials of Pediatric Hematology/Oncology Nursing: A Core Curriculum (4th ed.) Association of Pediatric Hematology/Oncology Nurses.


Lal, A. (2017). Assessment and treatment of pain in thalassemia. The New York Academy of Sciences, 1368(1), 65-72. doi: 10.1111/nyas.13061


Musallam, K. M., Taher, A. T., & Rachmilewitz, E. A. (2017). β-thalassemia intermedia: a clinical perspective. Cold Spring Harbor Perspectives in Medicine, 2(7), a013482. doi: 10.1101/cshperspect. a013482


Pepe, A., Meloni, A., Rossi, G., Caruso, V., Cuccia, L., Spasiano, A., Gamberini, M.R. (2017). Cardiac complications and diabetes in thalassemia major: a large historical multicenter study. European Heart Journal-Cardiovascular Imaging, 19(3), 299-309. doi: 10.1111/bjh.12557


Sleiman, J., Tarhini, A., & Bou-Fakhredin, R. (2018). Non-transfusion-dependent thalassemia: An update on complication and management. International Journal of Molecular Science, 19(1), 182. doi: 10.3390/ijms19010182.


Vichinsky, E. (2016). Non-transfusion-dependent thalassemia and thalassemia intermedia: epidemiology, complication, and management. Current Medical Research, 32(1), 191-204. doi: 10.1185/03007995.2015.1110128


Vitamin B12 Deficiency


Boucher, M., Bryan, S., & Dukes, S. (2015). Deficiency or dementia? Exploring B12 deficiency after urostomy. British Journal of Nursing, 24(11), 594-597. Doi:10.12968/bjon.2015.24.11.594


Hollier, A. (Ed.). Vitamin B12 deficiency. In Clinical Guidelines in Primary Care. (3rd ed.). Advanced Practice Education Associates.


Langan, R. C., & Goodbred, A. J. (2017). Vitamin B12 deficiency: recognition and management. American Family Physician, 96(6), 384-389. https://www.aafp.org/afp/2017/0915/p384.html


Shipton, M., & Thachil, J. (2015). Vitamin B12 deficiency – A 21st century perspective. Clinical Medicine, 15(2), 145-50. Doi:10.7861/clinmedicine.15-2-145.


Sukumar, N. (2019). Investigating vitamin B12 deficiency. BMJ 365, 1865. doi: 10.1136/bmj.l1865




Didn't find what you were looking for?